When Wayne and I first decided to start Crowdability nearly five years ago, we ran the idea past a bunch of our Venture Capitalist (“VC”) friends. As we explained, our goal was to teach everyone how to make money investing in start-ups.
In a 2011 Huffington Post article, the author explained why the “best and brightest” college graduates were heading to Wall Street: “It’s basic human nature,” she wrote. “Follow the money.” Makes sense.
Although most cryptos have experienced a pullback over the past few weeks, one corner of the crypto market continues to shine: ICOs. ICOs, short for Initial Coin Offerings, continue to be one of the most profitable ways to invest in crypto-currencies.
At Crowdability, Wayne and I help you earn big gains from exciting investments like start-ups and crypto-currencies. But we also do something else: We aim to protect you — especially by helping you steer clear of investments that are “too good to be true” or downright scams.
Investing in biotech companies has made a lot of people very wealthy. And it’s easy to see why: Over the years, shares of big names like Merck have skyrocketed from just a dollar or two to $60 or more.
For the last twenty years, Wayne and I have been “hooked” on investing in pre-IPO start-ups. We still invest in traditional assets like stocks, bonds, and real estate...
For the last two weeks, Wayne and I have been telling you about an extraordinary investment opportunity. To sum things up: According to a leaked document that came into our possession, Wall Street is perhaps just weeks away from pouring billions of dollars into the crypto-currency market...
In last week’s newsletter, Wayne and I revealed what could turn out to be one of the most profitable discoveries of our careers... You see, we recently came into possession of a confidential document, leaked from an elite Wall Street financial institution.